Cohance Lifesciences Limited: Detailed financials

Line items extracted directly from the company's exchange-filed XBRL. Click + to expand subtotals. Click any row to chart it. Monetary values are in ₹ crore.

Company financials

Particulars	Dec-24	Mar-25	Jun-25	Sep-25	Dec-25	Mar-26	Jun-26	Sep-26
	307	402	549	556	545	619	422	477
	16	11	14	16	6	−2	12	12
	213	361	493	487	505	581	477	500
	67	70	178	192	197	139	159	237
	−11	64	−30	−50	−38	75	−38	−98
	63	89	133	127	119	129	133	154
	3	6	10	9	9	9	7	8
	20	27	45	44	47	51	50	50
	71	105	156	167	172	177	168	149
	133	84	118	137	97	80	13	48
	113	57	73	93	50	29	−36	−2
	—	—	−8	—	−5	−17	—	—
	110	52	63	84	41	20	−43	−11
	26	13	16	17	12	12	2	−13
	83	39	46	66	29	8	−45	2
Financial ratios
	43.43%	20.93%	21.50%	24.58%	17.75%	12.97%	3.18%	10.03%
	27.12%	9.63%	8.45%	11.95%	5.33%	1.34%	-10.70%	0.48%
	3.26	1.65	1.28	1.94	0.96	0.51	-0.63	0.40

Revenue

₹ crore

Select any table row to compare its reported history.

Source: official NSE or BSE financial-result filings & XBRL. Figures are exact values reported by the issuer at filing time, never estimated. Derived margins, subtotals, leverage and cash-flow measures use only the displayed filed line items.